SAU:4015'
s ROA % Range Over the Past 10 Years
Min: 11.66 Med: 16.47 Max: 24.3
Current: 23.31
During the past 6 years, Jamjoom Pharmaceuticals Factory Co's highest ROA % was 24.30%. The lowest was 11.66%. And the median was 16.47%.
SAU:4015's ROA % is ranked better than 97.31% of 1004
companies
in the Drug Manufacturers industry
Industry Median: 2.75
vs SAU:4015: 23.31
Jamjoom Pharmaceuticals Factory Co (SAU:4015) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Jamjoom Pharmaceuticals Factory Co ROA % Related Terms
Jamjoom Pharmaceuticals Factory Co ROA % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Jamjoom Pharmaceuticals Factory Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jamjoom Pharmaceuticals Factory Co ROA % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jamjoom Pharmaceuticals Factory Co's ROA % distribution charts can be found below:
* The bar in red indicates where Jamjoom Pharmaceuticals Factory Co's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Jamjoom Pharmaceuticals Factory Co (SAU:4015) has a ROA % of 32.38% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Jamjoom Pharmaceuticals Factory Co and its competitors. This is 97% above median its historical median of 16.47. Over the past decade, Jamjoom Pharmaceuticals Factory Co's ROA % has ranged from 11.66 to 24.30. According to the industry distribution chart, Jamjoom Pharmaceuticals Factory Co ranks #27 out of 1004 companies in the Drug Manufacturers industry, placing it in the top 2.7%.
Is Jamjoom Pharmaceuticals Factory Co's ROA % too high?
Jamjoom Pharmaceuticals Factory Co's current ROA % of 32.38% is 97% above median its 10-year median of 16.47. Over the past 10 years, this metric has ranged from a low of 11.66 to a high of 24.30. The Drug Manufacturers industry median ROA % is 2.75. Jamjoom Pharmaceuticals Factory Co's value of 32.38% is 1077.5% above this industry median. Based on the distribution chart, Jamjoom Pharmaceuticals Factory Co ranks #27 out of 1004 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Jamjoom Pharmaceuticals Factory Co has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jamjoom Pharmaceuticals Factory Co's ROA % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jamjoom Pharmaceuticals Factory Co ranks #27 out of 1004 companies for ROA %. This places Jamjoom Pharmaceuticals Factory Co in the top 3% of its industry — outperforming the majority of peers. The industry median ROA % is 2.75. Jamjoom Pharmaceuticals Factory Co's value of 32.38% is 1077.5% above this benchmark. Historically, Jamjoom Pharmaceuticals Factory Co's own ROA % has ranged from 11.66 to 24.30 over the past decade. While the company's 10-year median is 16.47 vs. the industry median of 2.75, Jamjoom Pharmaceuticals Factory Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Drug Manufacturers company?
The median ROA % among Drug Manufacturers companies is 2.75, based on 1,004 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jamjoom Pharmaceuticals Factory Co's current ROA % of 32.38% is 1077.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Jamjoom Pharmaceuticals Factory Co and its competitors. For the Drug Manufacturers industry, the median ROA % is 2.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jamjoom Pharmaceuticals Factory Co's current ROA % is 32.38%, which is 97% above median its own 10-year median of 16.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jamjoom Pharmaceuticals Factory Co stock overvalued right now?
Based on GuruFocus' analysis, Jamjoom Pharmaceuticals Factory Co (SAU:4015) is currently considered Modestly Undervalued. The stock's GF Value™ is ﷼181.81, compared to a current price of ﷼157.00 — trading 13.6% below its estimated fair value. The current ROA % is 32.38%, which is 97% above median its 10-year median of 16.47 and 1077.5% above the Drug Manufacturers industry median of 2.75. Jamjoom Pharmaceuticals Factory Co's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Jamjoom Pharmaceuticals Factory Co (SAU:4015), the current ROA % is 32.38% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jamjoom Pharmaceuticals Factory Co (SAU:4015) Overvalued in 2026?
Based on GuruFocus' analysis, Jamjoom Pharmaceuticals Factory Co stock appears to be undervalued.
The current stock price of ﷼157.00 is trading 13.6% below its estimated GF Value™ of ﷼181.81.
GuruFocus considers Jamjoom Pharmaceuticals Factory Co to be Modestly Undervalued.
Key valuation signals for SAU:4015:
ROA %: 32.38% (97% above median its 10-year median of 16.47)
GF Value™: ﷼181.81 vs. price of ﷼157.00 (13.6% below fair value)
Industry Position: 1077.5% above the Drug Manufacturers median (#27 of 1004)
No single metric tells the full story. See the SAU:4015 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jamjoom Pharmaceuticals Factory Co Business Description
Jamjoom Pharmaceuticals Factory Co is engaged in producing human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer and acidity, treatment of various skin infections, cancer diseases, eye drops and ointments and cosmeceuticals. Geographically the company has a presence in the Kingdom of Saudi Arabia, the Gulf, Iraq, Egypt, North Africa, and other export markets.
73GF Score
Get the complete analysis for SAU:4015
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4015 has been successfully added to your 
